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The decay of several yeast mRNAs occurs by a mechanism in which deadenylation precedes decapping and
subsequent 5*-to-3* exonucleolytic decay. In order to identify gene products required for this process of mRNA
turnover, we screened a library of temperature-sensitive strains for mutants with altered mRNA degradation.
We identified seven mutations in four genes that inhibited mRNA turnover. Two mutations were alleles of the
XRN1 5*-to-3* exoribonuclease known to degrade mRNAs following decapping. One mutation defined a new
gene, termed DCP1, which in subsequent work was demonstrated to encode a decapping enzyme or a necessary
component of a decapping complex. The other mutations defined two additional genes, termed MRT1 and
MRT3 (for mRNA turnover). Mutations in the MRT1 and MRT3 genes slow the rate of deadenylation-
dependent decapping, show transcript-specific effects on mRNA decay rates, and do not affect the rapid
turnover of an mRNA containing an early nonsense codon, which is degraded by a deadenylation-independent
decapping mechanism. Importantly, cell extracts from mrt1 and mrt3 strains contain normal levels of the
decapping activity required for mRNA decay. These observations suggest that the products of the MRT1 and
MRT3 genes function to modulate the rates of decapping that occur following deadenylation.
The process of mRNA turnover is a critical step in deter-
mining the regulation and levels of gene expression (for re-
views, see references 3, 6, and 30). In eukaryotic cells, a major
pathway of mRNA turnover is initiated by shortening of the
poly(A) tail, which is followed by degradation of the transcript
body (for reviews, see references 1 and 9). In Saccharomyces
cerevisiae, mRNA deadenylation leads to removal of the 59 cap
structure of mRNAs (decapping) and then rapid 59-to-39 exo-
nucleolytic digestion of the mRNA body (8, 16, 21, 22). Al-
though there is no direct evidence for decapping being a step
in mRNA decay in more complex eukaryotes, mRNAs lacking
the cap structure are rapidly degraded in many eukaryotic cells
(e.g., see reference 10) and enzymatic activities that could
catalyze the removal of the cap structure and subsequent 59-
to-39 degradation of the transcript have been identified in
mammalian cells (e.g., see reference 7). Thus, deadenylation-
dependent decapping followed by 59-to-39 exonucleolytic decay
may be a conserved mechanism of eukaryotic mRNA degra-
dation.
Since decapping is the final step that leads to degradation of
the transcript body, decapping rates significantly affect mRNA
decay rates. Thus, decapping rates are controlled by several
inputs. For example, the unstable MFA2 mRNA is rapidly
decapped following deadenylation, while the stable PGK1 tran-
script is decapped slowly after deadenylation (8, 21, 22). Dif-
ferences in decapping rates are at least partially determined by
specific sequences within these mRNAs (21–23). Similarly, the
major effect of the poly(A) tail on mRNA stability appears to
be an inhibition of decapping (5). Finally, early nonsense
codons promote extremely rapid mRNA decay by triggering
decapping independently of deadenylation (24). Given the im-
portance of decapping, a knowledge of the mechanisms and
control of mRNA decapping will be essential to understanding
the process of mRNA decay.
To identify gene products required for mRNA decapping, a
library of temperature-sensitive strains was screened for mu-
tants with altered mRNA degradation. We identified seven
mutations in four genes that inhibited mRNA turnover. Two
mutations were alleles of the XRN1 59-to-39 exoribonuclease
known to degrade mRNAs following decapping (16, 21, 22).
One mutation defined a new gene, termed DCP1, which in
subsequent work was demonstrated to encode a component of
the decapping enzyme (2). The other mutations defined two
additional genes, termed MRT1 and MRT3 (for mRNA turn-
over), whose gene products are required for mRNA decap-
ping. Interestingly, the rapid turnover of an mRNA containing
an early nonsense codon, which is degraded by a deadenyla-
tion-independent decapping mechanism (24), was not inhib-
ited in the mrt1 and mrt3 strains. These observations suggest
that theMRT1 andMRT3 gene products modulate the rates of
decapping that occur following deadenylation.
MATERIALS AND METHODS
Plasmid construction. The plasmid pRP484 was used for integrating the
MFA2pG and PGK1pG genes under the transcriptional control of the GAL1
upstream activation sequence (UAS), along with the LEU2 gene as a marker
(collectively termed LEU2 [PM]), into the CUP1 locus. By standard cloning
techniques, pRP484 was derived from pRP480, which contains the following
sequences located in the polylinker region of the LEU2 integration vector
pRS405 (33). An ;450-bp Sau3A-EcoRI fragment containing sequences from
the 59 region of the CUP1 locus was isolated from pUC8-cup1s (12) after filling
the EcoRI site with Klenow and was located between the BamHI and PstI-
Klenow-filled polylinker site. An ;1,200-bp HindIII-XhoI fragment containing
sequences from the 39 region of the CUP1 locus was isolated from pBS-Cup-Sma
(20) after the SmaI site had been changed to an XhoI site by linker insertion and
was located between the HindIII and XhoI sites of the polylinker. An SphI-XhoI
fragment containing the GAL1 UAS and PGK1pG transcription unit was iso-
lated from pRP469 (8) after the HindIII site was changed to XhoI by linker
insertion and the SphI site was filled with Klenow. This fragment was oriented
within the XhoI site with the blunt-ended SphI end at the insert-vector junction.
The XhoI site at the insert-vector junction was lost in pRP480. To create the
insertion plasmid pRP484, XhoI linkers were added to the PvuII-HindIII frag-
ment containing the GAL1 UAS and the MFA2pG transcription unit from
pRP485 (8) prior to insertion into the unique XhoI site at the PGK1pG frag-
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ment-39 CUP1 junction of pRP480. The promoter-proximal end of this DNA
insertion is adjacent to the 59 CUP1 sequence as determined by DNA sequencing
(data not shown).
Yeast strains and screening of the temperature-sensitive mutant yeast collec-
tion. The mrt and dcp1-1 and other strains used in this study are listed in Table
1. The mrt and dcp1-1 strains were obtained from at least two backcrosses of the
original mutants obtained from the screen.
The starting yeast strains for this project were constructed in the following
manner. First, by utilizing the HO gene (15), two isogenic MATa and MATa
strains, yRP685 and yRP684, were constructed. Each of these strains was then
transformed with HindIII-linearized pRP484, thereby integrating at the CUP1
locus the PGK1pG and MFA2pG genes under the control of the GAL1 UAS
(termed PM). All integrations were confirmed by Southern analysis (data not
shown). To facilitate selection of diploids during subsequent analysis, yRP839
(yRP685 with PM) was transformed with a 4.5-kb fragment of the LYS2 gene,
thereby creating yRP840. Similarly, yRP838 was transformed with a 3.3-kb frag-
ment of the HIS4 gene, thereby creating yRP841.
A temperature-sensitive library was constructed by standard ethyl methane-
sulfonate mutagenesis, yielding 640 and 262 temperature-sensitive strains from
yRP840 and yRP841, respectively. This library was screened by Northern analysis
with RNA prepared (4) after growing cells at 368C for 1 h. In this screen,
oligonucleotide probes specific for either the PGK1pG (oRP141) (5) or the
MFA2pG (oRP140) (5) mRNA and their corresponding decay fragments were
used to examine the effects of mutations on both transcripts. These probes are
complementary to a portion of the poly(G) insertion (8) and to MFA2 or PGK1
sequences just 39 of the insertion.
Genetic analysis of mrt and dcp1-1 mutants and linkage of mRNA phenotype
with temperature-sensitive growth. The original temperature-sensitive mutants
were first backcrossed at least twice to the parental strains yRP840 and yRP841.
In each case, spores from multiple tetrads were examined both for temperature-
sensitive growth and, by Northern analysis, for alterations in mRNA decay. In
each case, analysis of more than 20 tetrads indicated that the mutant mRNA
phenotype segregated 2:2, indicating that it was due to a single lesion. For mrt1
alleles, the mRNA phenotype was always linked to the temperature sensitivity
(25 tetrads), indicating that the mrt1 alleles cause temperature-sensitive growth.
Novelty ofMRT genes with respect to other genes whose products are involved
in mRNA stability in S. cerevisiae. The DCP1 gene has been shown to encode a
component of the decapping enzyme (2). To determine if the other isolated
mutants represented alleles of either the XRN1, CCA1, or DCP1 gene, we
transformed each mutant with a centromere plasmid carrying these genes, ex-
pressed under their native promoters (pRP635, pRP636, and pRP717, respec-
tively) and examined the growth and mRNA phenotypes. Two of the isolates
were complemented by the XRN1 plasmid, indicating that these were new alleles
of XRN1. This was also confirmed by linkage analysis by a cross to an xrn1D strain
(yRP884). None of the mutants were complemented by the CCA1 gene. Neither
mrt1-3 nor mrt3-1 was complemented by the DCP1 gene, suggesting that the
mrt1-3 and mrt3-1 lesions were not in the DCP1 gene. This conclusion was
confirmed by linkage analysis by crossing yRP1066 (mrt1-3) and yRP1067
(mrt3-1) to a dcp1D strain, yRP1069.
Complementation and linkage analysis of mrt mutants. By standard tech-
niques, mrt1-1, mrt1-2, mrt1-3, dcp1-1, and mrt3-1 were examined by both
complementation analysis (examining both growth and mRNA phenotypes) and
pairwise linkage analysis (examining mRNA phenotypes). This defined three
unlinked complementation groups, which we defined as MRT1, DCP1, and
MRT3.
Suppression of pab1D by mrt and dcp1 mutations. To examine if the mrt1-2,
mrt1-3, dcp1-1, and mrt3-1 lesions would suppress pab1D, these mutants were
crossed to yRP850 (pab1::URA3) bearing pAS137 (see reference 5). Diploids
auxotrophic for tryptophan (diploids which lost the pAS137 PAB1 plasmid) were
sporulated, and their spores were dissected by standard procedures. The pre-
dominance of tetrads exhibiting a 3:1 growth ratio (three spores viable to one
dead spore) and a 1:3 URA1 ratio (only one viable URA1 spore) was inter-
preted to suggest that the mrt and dcp1-1 mutations and pab1D were unlinked
and that the mrt and dcp1-1 mutations suppress pab1D lethality. dcp1-1 sup-
pressed pab1D only if spores were grown at 248C; therefore, spores from all
crosses were grown at 248C. The steady-state MFA2pG mRNA distributions
from the mrt1-3 (yRP1066)-and-pab1::URA3 cross supported our interpretation
of the tetrad analysis showing one wild-type spore, one mrt1-3 spore, and a
unique mRNA phenotype in the mrt1-3 pab1::URA3 spore (an apparent combi-
nation of both the mrt1-3 and pab1D [5] effects [data not shown] on MFA2pG
mRNA).
RNA analysis. Analysis of mRNA was done by the following previously pub-
lished procedures: RNA preparation (4), immunoprecipitations with antisera
directed against the cap structure (21, 25), RNase H reactions (23), primer
extension analysis (21), and measurements of mRNA half-lives by transcriptional
repression of the GAL1 UAS and by temperature shifts of rpb1-1 (26) strains
(27). Transcriptional pulse-chase experiments were done essentially as previously
described (8), except that cells were grown in minimal medium with 2% raffinose
and 2% sucrose as neutral carbon sources prior to a transcriptional induction
period of 8 min, without a temperature shift at the end of the induction period.
Cell-free decapping activity assays. Decapping activity was assayed after par-
tial purification as described by Beelman et al. (2). Wild-type (yRP840), mrt1-3
TABLE 1. Strains used in this study
Strain Mutant Genotype
yRP684 Wild type MATa trp1 ura3-52 leu2-3,112 his4-539 lys2-201
yRP685 Wild type MATa trp1 ura3-52 leu2-3,112 his4-539 lys2-201
yRP693 rpb1-1 MATa ura3-52 leu2-3,112 rpb1-1
yRP838 Wild type MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM) lys2-201
yRP839 Wild type MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM) lys2-201
yRP840 Wild type MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM)
yRP841 Wild type MATa trp1 ura3-52 leu2-3,112 lys2-201 cup1::LEU2 (PM)
yRP850 pab1D MATa trp1 ura3-52 leu2-3,112 pab1::URA3 cup1::LEU2 (PM) with pAS137
yRP881 spb2D pab1D MATa trp1 ura3-52 leu2-3,112 his4-539 spb2::URA3 pab1::URA3
yRP884 xrn1D MATa trp1 ura3-52 leu2-3,112 lys2-201 cup1::LEU2 (PM) xrn1::URA3
yRP890 dcp1-1 MDC1-1 MATa trp1 ura3-52 leu2-3,112 lys2-201 cup1::LEU2 (PM) dcp1-1 MDC1-1
yRP891 dcp1-1 MDC1-1 MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM) dcp1-1 MDC1-1
yRP892 dcp1-1 MATa trp1 ura3-52 leu2-3,112 lys2-201 cup1::LEU2 (PM) dcp1-1
yRP903 xrn1D pab1D MATa lys2 trp1 ura3 leu2 cup1::LEU2 (PM) xrn1::URA3 pab1::URA3
yRP1063 dcp1-1 MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM) dcp1-1
yRP1064 xrn1-230 MATa trp1 ura3-52 leu2-3,112 lys2-201 cup1::LEU2 (PM) xrn1-230
yRP1065 xrn1-428 MATa trp1 ura3-52 leu2-3,112 lys2-201 cup1::LEU2 (PM) xrn1-428
yRP1066 mrt1-3 MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM) mrt1-3
yRP1067 mrt3-1 MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM) mrt3-1
yRP1069 dcp1D MATa trp1 ura3-52 leu2-3,112 lys2-201 cup1::LEU2 (PM) dcp1::URA3
yRP1102 rpb1-1 MATa ura3-52 his4-539 rpb1-1
yRP1103 mrt1-3 rpb1-1 MATa ura3-52 mrt1-3 rpb1-1
yRP1104 dcp1-1 rpb1-1 MATa ura3-52 dcp1-1 rpb1-1
yRP1105 mrt3-1 rpb1-1 MATa ura3-52 his4-539 mrt3-1 rpb1-1
yRP1130 mrt1-3 pab1D MATa trp1 ura3-52 leu2-3,112 his4-539 pab1::URA3 cup1::LEU2 (PM) mrt1-3
yRP1131 mrt1-2 pab1D MATa trp1 ura3-52 leu2-3,112 his4-539 pab1::URA3 cup1::LEU2 (PM) mrt1-2
yRP1132 dcp1-1 pab1D MATa trp1 ura3-52 leu2-3,112 his4-539 pab1::URA3 cup1::LEU2 (PM) dcp1-1 MDC1-1
yRP1133 mrt3-1 pab1D MATa trp1 ura3-52 leu2-3,112 his4-539 pab1::URA3 cup1::LEU2 (PM) mrt3-1
yRP1134 mrt1-2 MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM) mrt1-2
yRP1135 mrt1-1 MATa trp1 ura3-52 leu2-3,112 his4-539 cup1::LEU2 (PM) mrt1-1
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(yRP1066), and mrt3-1 (yRP1067) cells were grown in yeast extract-peptone-
dextrose (YEPD) medium, and the decapping enzymatic activity was eluted from
the heparin-agarose column with buffer A containing 700 mM (NH4)2SO4.
RESULTS
Strategy. The approach that we utilized to identify gene
products involved in mRNA decay was to screen a collection of
approximately 900 temperature-sensitive mutants for lesions
that alter the normal pathway of mRNA decay (Fig. 1A). The
logic behind this screen was that mutations that inhibit mRNA
degradation were expected to increase the levels of full-length
mRNA and reduce or abolish the levels of decay products. The
major observed decay product corresponds to a fragment pro-
duced by 59-to-39 exonucleolytic digestion to an insertion of a
poly(G) tract (pG) into the 39 UTR (8) (depicted in Fig. 1A).
This pG insertion forms a strong secondary structure that
inhibits exonucleases, thereby stabilizing this decay fragment
(e.g., see reference 8). An example of the assay used is shown
in Fig. 1B, in which a strain where the XRN1 gene was deleted,
which encodes the 59-to-39 exoribonuclease responsible for
mRNA degradation (16, 19, 21, 22), accumulated full-length
MFA2 transcripts and showed a decrease in the levels of decay
product.
The isolation of mrt mutants. As the first step in this screen,
we constructed a pair of strains in which the PGK1 and MFA2
genes containing the 39 UTR pG insertion, termed PGK1pG
and MFA2pG, were integrated into the genome. In addition,
to allow subsequent analysis, the PGK1pG and MFA2pG
genes were under the control of the GAL1 UAS (see below).
Following mutagenesis and purification, approximately 900
temperature-sensitive strains were screened by Northern anal-
ysis for accumulation of full-length PGK1pG and MFA2pG
transcripts and a corresponding decrease in the levels of their
decay products.
Seven different strains were identified that showed an in-
crease in the levels of full-length mRNA and a decrease in the
levels of decay product (similar to the xrn1D phenotype shown
in Fig. 1B). Genetic analysis of these isolates demonstrated the
following points (see Materials and Methods for details). (i) In
each case, the alteration in the distribution between full-length
mRNA and decay product was due to a single genetic locus. (ii)
One of the mutations, originally termed mrt2-1, was in the
DCP1 gene, which appears to encode an essential component
of the decapping enzyme (2). This point mutation in the DCP1
gene was subsequently named dcp1-1. (iii) None of the muta-
tions were in the CCA1 gene, which is thought to affect mRNA
decay indirectly by inhibiting translation elongation (28). (iv)
Two of the mutants carried new alleles of XRN1, which we
have termed xrn1-230 and xrn1-428. (v) The remaining four
mutations defined two different genes. On the basis of these
observations, we concluded that we had identified mutations in
two genes that affect mRNA turnover (see results below). We
termed these genes MRT1 (three alleles [mrt1-1, mrt1-2, and
mrt1-3]) and MRT3 (one allele [mrt3-1]).
The mrt1 and dcp1-1 mutations can affect growth at high
temperature. Because of the library screened, each original
isolate in this screen was temperature sensitive for growth at
368C. To determine if this conditional growth was due to the
mrt or dcp1-1 alleles, we examined whether the alteration in
mRNA distributions and temperature sensitivity cosegregated
in backcrosses of the mutants to wild-type strains. For the
mrt3-1 mutation and the alleles of XRN1, the temperature
sensitivity and the alteration in mRNA distribution segregated
away from each other. These mutants did not prevent growth
at any temperature tested. In contrast, in mrt1-1, mrt1-2, and
mrt1-3 strains, the mutation responsible for the mRNA phe-
notype cosegregated with conditional lethality in 25 tetrads,
indicating that these lesions in the MRT1 gene cause temper-
ature-sensitive growth. It should be noted, however, that the
alteration in mRNA distribution was seen at both the permis-
sive and nonpermissive temperatures for all three mrt1 alleles.
It is, therefore, possible that effects on mRNA decay are lethal
only when the cells are grown at 368C or that the mrt1 lesions
cause lethality at 368C because of loss of a second, essential
function.
The linkage between the effects on mRNA distribution and
growth at 368C for the dcp1-1mutation was complex. Although
in every tetrad two spores showed alteration in mRNA distri-
butions (as judged by Northern analysis), only one-half of the
spores with a mutant mRNA phenotype and none of the wild-
type spores from the first backcross were temperature sensi-
tive. These results suggested that a second, unlinked mutation,
which we termed MDC1-1 (modifier of dcp1), caused dcp1-1
strains to be temperature sensitive.
To test this model, two crosses were performed (for a similar
analysis discussed in more detail, see reference 18). First, a
four-spore tetrad was identified in the dcp1-1 backcross in
which no spores were temperature sensitive, suggesting that
the modifier had segregated away from the dcp1-1 allele and
was present in the spores that do not show an alteration in
mRNA distribution. Such a spore was picked and then crossed
to a temperature-sensitive dcp1-1 strain, which would be ex-
pected to give a diploid homozygous for the modifier mutation.
As predicted, dissection of this diploid gave 2:2 segregation for
temperature sensitivity with each temperature-sensitive spore
showing alterations in mRNA distributions. Additional evi-
dence for such a modifier mutation came from taking a spore
from a tetrad similar to that described above, which was pre-
dicted to have the dcp1-1 allele but not the modifier lesion, and
by backcrossing it to the wild type. As predicted, dissection of
this diploid, which would be lacking the modifier, gave 2:2
segregation for alterations in the mRNA phenotype; however,
no spores were temperature sensitive. The modifier mutation,
termedMDC1-1, was later seen to be dominant, since a diploid
homozygous for dcp1-1 and heterozygous for the modifier mu-
tation was temperature sensitive.
The MDC1-1 mutation had no phenotype by itself with re-
spect to cell growth or mRNA decay (data not shown) but was
FIG. 1. Strategy to isolate mutations affecting mRNA decay. (A) A common
pathway of mRNA degradation in S. cerevisiae. In the schematic, the shaded box
labeled pG represents the site of insertion of the poly(G) tract, which serves as
a barrier to exonucleases. (B) A Northern blot illustrating the different steady-
state distributions of full-length MFA2pG mRNA and its corresponding decay
product seen in wild-type (WT), yRP840, and xrn1D, yRP884 strains. The probe
for this experiment was an oligonucleotide, oRP140 (5), which hybridizes to the
junction of the poly(G) insertion and the MFA2 39 UTR sequences and is
therefore specific for the MFA2pG transcript and its decay product.
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synthetically temperature sensitive with the dcp1-1 mutation.
This indicated that the dcp1-1 mutation itself does not limit
growth at high temperature but can become required when
combined with a second lesion. Although the basis for the
temperature sensitivity of the dcp1-1 MDC1-1 mutant is un-
known, it can be suppressed by expression of the DCP1 gene
(2). This observation implies that the temperature-sensitive
phenotype is due, at least in part, to a defect in mRNA decap-
ping (see below).
mRNAs are stabilized in mrt and dcp1-1 mutant strains. To
determine if the changes in distribution between full-length
mRNA and decay products were due to a change in the mRNA
decay rate, we measured the half-lives of the MFA2pG and
PGK1pG mRNAs in wild-type, dcp1-1, and mrt mutant strains.
In these experiments, cells were grown in media containing
galactose and transcription of the MFA2pG and PGK1pG
mRNAs was repressed by the addition of glucose (27). Com-
parison of the decay rates of the indicated mutants showed
rates of decay two- to fourfold lower than those seen in wild-
type cells for the MFA2pG (Fig. 2) and PGK1pG transcripts
(Table 2). It should be noted that the decay rate of the
PGK1pG transcript in this wild-type strain is slightly higher
than that previously reported (e.g., see reference 27) because
of the different strain background. The observation that the
mrt1-3, dcp1-1, and mrt3-1 mutations affected mRNA decay
rates demonstrated that the MRT1, MRT3, and DCP1 gene
products are required for normal rates of mRNA turnover.
The mrt1 and mrt3 mutations affect mRNA decapping. In
principle, the mrt1, mrt3, and dcp1-1 mutations could affect
mRNA decay by slowing deadenylation, decapping, and/or 59-
to-39 digestion. We have recently cloned the DCP1 gene and
shown that this gene encodes a component of the decapping
enzyme (2). Accordingly, loss-of-function mutations in the
DCP1 gene lead to a block of decapping in vivo (2). To deter-
mine the step(s) in the decay pathway affected by lesions in the
MRT1 and MRT3 genes, we analyzed the decay of the
MFA2pG transcript in these mutant strains by transcriptional
pulse-chase analysis (8). In this type of experiment, carbon
source regulation of the GAL1 UAS is utilized to rapidly in-
duce and then repress transcription, thereby producing a pool
of newly made transcripts the turnover of which can be mon-
itored over time to observe rates of deadenylation and subse-
quent decay of the MFA2pG transcript.
Decay of the MFA2pG transcript in wild-type, mrt1-3, and
mrt3-1 strains is shown in Fig. 3 and reveals two important
observations. First, the deadenylation rate for the MFA2pG
mRNA was not significantly different in the mrt1-3 and mrt3-1
mutants from that in wild-type cells (cf. bottom of bands in 0-
through 8-min lanes in Fig. 3). Second, both mutant strains
showed an accumulation of full-length deadenylated tran-
scripts relative to the wild-type strain (cf. 30-min lanes). We
interpret these observations to indicate that the primary effect
of the mrt lesions on mRNA decay is to affect steps that occur
after deadenylation, such as decapping and/or 59-to-39 exonu-
clease digestion.
To distinguish whether the mrt1 and mrt3 mutations blocked
mRNA decapping or 59-to-39 exonuclease digestion, we uti-
FIG. 2. MFA2pG mRNA is stabilized in mrt and dcp1-1 mutants. The figure
shows measurement of the decay rate of the MFA2pG mRNA in wild-type, mrt,
and dcp1-1 strains on a Northern blot following the inhibition of transcription by
the addition of glucose to the growth media. The time points represent minutes
after the addition of glucose to the media. The strains utilized were wild type
(WT) (yRP840), mrt1-3 (yRP1066), dcp1-1 (yRP890), and mrt3-1 (yRP1067).
Other alleles of MRT1, mrt1-1, and mrt1-2 exhibit a similar stabilization of
MFA2pG mRNA as seen in the mrt1-3 mutant (data not shown). The xrn1-230
and xrn1-428 mutants isolated in this screen both yield MFA2pG half-lives of
approximately 9 min (data not shown). To specifically detect the MFA2pG
transcript and its decay product, the oligonucleotide oRP140 (5) was used as the
probe. FL, full length; frag., fragment.
FIG. 3. mrt mutations inhibit mRNA decay after deadenylation; transcrip-
tional pulse-chase analysis of the decay of the MFA2pG transcript in wild-type
(yRP840 [WT]) and mrt strains. MFA2pG mRNA was analyzed on a 6% acryl-
amide–8 M urea Northern gel. Numbers above the lanes are minutes after
transcriptional repression by the addition of glucose following an 8-min induc-
tion of transcription (see reference 8). The mutant strains utilized were mrt1-3
(yRP1066) andmrt3-1 (yRP1067), and the blot was probed with oRP140 (5). The
positions of fully deadenylated MFA2pG transcripts are shown on the right,
based on lanes in which the RNA was treated with RNase H and oligo(dT) prior
to electrophoresis (not shown). In wild-type cells, the decay product arising from
59-to-39 exonucleolytic decay accumulates beginning at the 8-min time point (not
shown). In the mrt strains, the appearance of this decay fragment is severely
reduced or abolished in the transcriptional pulse-chase experiment (data not
shown; see Fig. 2 for steady-state comparison).
TABLE 2. mRNA half-lives in wild-type and mrt strains
mRNA
Half-life (min)a
Wild type mrt1-3 mrt3-1
PGK1pG 22.5 47.8 41.8
PAB1 20.8 20 14.5
Pre-CYH2 ,2 ,2 ,2
CYH2 26 48.5 38
HIS3 7 17 16.5
GAL10 5 17 6.2
MFA2pG 3.5 16 7
a Half-lives are based on multiple determinations and typically vary by less
than 20% between individual experiments.
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lized antisera directed against the 59 cap structure to separate
steady-state mRNA from wild-type cells and mrt mutants into
capped and decapped populations (21, 22). Mutations that
block 59-to-39 exonucleolytic digestion, such as xrn1D, are
known to accumulate deadenylated, decapped transcripts (16,
21, 22). In contrast, lesions that inhibit decapping were ex-
pected to accumulate deadenylated, capped transcripts. In
keeping with the transcriptional pulse-chase analysis, examina-
tion of the MFA2pG mRNA present in the mrt mutants at
steady-state indicated that these mutants accumulated full-
length, deadenylated transcripts (Fig. 4 [T lanes]). As seen in
the lanes containing immunoprecipitated RNA in Fig. 4 (P
lanes), both of the mrt mutants accumulated a deadenylated
species that was immunoprecipitable, indicating that these full-
length deadenylated transcripts are capped. In contrast, xrn1D
strains accumulated a deadenylated species that lacks the 59
cap, as judged by their presence in the soluble fraction. These
observations indicated that themrt1 andmrt3mutations inhibit
decapping of the MFA2pG transcript.
To obtain additional evidence that the mrt1 and mrt3 muta-
tions inhibit decapping, we took advantage of the observation
that the decapped PGK1pG transcripts that accumulate in
xrn1D strains are shorter at their 59 ends by two nucleotides
(21, 22). We determined if decapped PGK1pG transcripts ac-
cumulated in the mrt mutants by examining the 59 end of
PGK1pG mRNA in these strains by primer extension analysis.
If decapping is blocked in an mrt mutant, then full-length
(capped) PGK1pG transcripts would be expected to accumu-
late in these strains (labeled FL in Fig. 5). This can be seen in
dcp1-1 strains (Fig. 5 [dcp1-1 lane]), which are deficient in
decapping activity (2). Conversely, if 59-39 exonuclease diges-
tion is blocked in the mrt strains, as in the xrn1D strains, then
decapped transcripts should accumulate as cDNA extension
products that are shorter by two nucleotides (labeled 22 spe-
cies [Fig. 5, xrn1D lane]). As expected, in both the xrn1D and
the xrn1-230 strains, cDNA extension products shorter by 2
bases were observed. In contrast, only full-length cDNA prod-
ucts were observed in the mrt1 and mrt3 strains (Fig. 5). We
interpreted the results of this primer extension assay, in com-
bination with the results from the direct assay of cap immuno-
precipitations on MFA2pG mRNA described above, to indi-
cate that mutations in the MRT1 and MRT3 genes inhibit
mRNA decapping.
Lesions in the MRT1 and MRT3 genes affect the decay rates
of several endogenous transcripts. The degradation pathway
of deadenylation-dependent decapping has been speculated to
be a common pathway of yeast mRNA decay (1, 9). Since the
mrt1 and mrt3 lesions affected decapping of MFA2pG and
PGK1pG mRNAs, we determined if these lesions affected the
turnover of additional yeast transcripts. To perform this exper-
iment, the mrt1-3 and mrt3-1 mutations were introduced into a
strain carrying a temperature-sensitive lesion in RNA polymer-
ase II (rpb1-1) (26). Subsequently, transcription in these strains
was inhibited by shifting the cells to 368C, and the decay of a
number of endogenous mRNAs over time was monitored (14,
27). The temperature shift is not expected to change the effects
of the mrt mutations on mRNA decay, because the alterations
in mRNA distribution between full-length mRNA and decay
product due to the mrt mutations are the same at both 24 and
368C (data not shown). As summarized in Table 2, both the
mrt1 and the mrt3 mutations affected the degradation of a
number of different cellular mRNAs, suggesting that the func-
tion of the MRT gene products in mRNA decay is relatively
general (see discussion). The stabilization effect was greatest
for unstable mRNAs, such as the HIS3 and MFA2pG tran-
scripts. This is presumably because the normal rate of decap-
ping and 59-to-39 decay of these mRNAs is much faster than
the rates of possible alternative mRNA decay mechanisms for
these transcripts (such as 39-to-59 decay). Thus, a block in
decapping will have a more dramatic effect on HIS3 and
MFA2pG mRNA stability compared with more stable tran-
scripts, such as PGK1pG, that undergo both slow 59-to-39 de-
cay and slow 39-to-59 decay (see reference 22 for discussion).
Interestingly, although the mrt1-3 mutation stabilized the
GAL10 transcript by three- to fourfold compared with the
wild-type strain, themrt3-1mutation did not significantly affect
the decay rate of this transcript. This observation implied that
mRNA-specific interactions with the MRT gene products may
play a role in differential rates of mRNA decapping and decay
(see discussion).
The stability of the PAB1 transcript was not affected by mrt1
ormrt3mutations. Moreover, the stability of this transcript was
not affected in dcp1-1 strains (data not shown). These obser-
vations show that mRNA stability is not increased by default in
FIG. 4. mrt mutants accumulate deadenylated, capped transcripts; immuno-
precipitation of MFA2pG mRNA with antisera directed against the cap struc-
ture. Following immunoprecipitation of total RNA under steady-state conditions
(prepared from cells growing in media containing galactose), the RNA was
analyzed on polyacrylamide Northern gels, and probe oRP140 (5) was used to
visualize MFA2pG mRNA. Lanes: T, total RNA before immunoprecipitation; P,
pellet (immunoprecipitable fraction); S, supernatant. Since some RNA is lost
during the immunoprecipitation protocol (8), the T lanes of the wild type
(yRP840), the mrt mutants mrt1-3 (yRP1066) and mrt3-1 (yRP1067), and the
xrn1D control (yRP884) show a lighter exposure than those of the immunopre-
cipitated fractions, thereby allowing a comparison of the poly(A) distribution in
each case. The small amount of the RNA that is not immunoprecipitable even in
the wild-type cells represents RNA that is capped but is not precipitated because
of the limited antisera utilized in these experiments. The use of increased
amounts of antisera precipitates these species (data not shown). M lanes, DNA
fragment size markers; dT lane, WT mRNA treated with oligo(dT) and RNase
H to show the size of full-length MFA2pG mRNA lacking poly(A) tails.
FIG. 5. Primer extension analysis of the PGK1 transcript in mrt mutants;
primer extension analysis of the PGK1 transcripts in various mutants affecting
mRNA decay. FL, the cDNA product corresponding to full-length PGK1 tran-
scripts; 22 species, the cDNA product previously shown to arise from a de-
capped PGK1 RNA (22). The labels above each lane indicate the strains from
which RNA was prepared (xrn1D [yRP884],mrt1-3 [yRP1066],mrt3-1 [yRP1067],
mrt1-1 [yRP1115], xrn1-230 [yRP1064], and mrt1-2 [yRP1114]). In this experi-
ment, the oligonucleotide used to prime cDNA synthesis (oRP131 [24]) produces
cDNA products from both the endogenous PGK1 gene and the integrated
PGK1pG construct.
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the mrt and dcp1 mutants and suggest that PAB1 mRNA may
be primarily degraded by an alternative decay mechanism.
PGK1pG mRNAs containing an early nonsense codon are
not stabilized in mrt mutant strains. In principle, the mrt1 and
mrt3 mutations could inhibit decapping in two general ways.
First, the MRT1 and MRT3 gene products could be direct
regulators of Dcp1p activity by promoting the synthesis or
increasing the activity of this decapping enzyme. Alternatively,
theMRT gene products might influence messenger ribonucleo-
protein (mRNP) structure after deadenylation, resulting in
increased accessibility of the 59 cap structure to the decapping
enzyme. To distinguish between these possibilities, we first
examined the degradation of transcripts containing early non-
sense codons in the mrt1 and mrt3 mutants. This experiment is
based on the observation that even though mRNAs containing
premature nonsense codons are decapped prior to deadenyla-
tion (24), these transcripts are decapped by the same enzyme
that decaps normal transcripts, Dcp1p (2). If themrt1 andmrt3
lesions directly affect the activity of the decapping enzyme,
then they would be expected to affect the decapping of a
transcript with an early nonsense codon. Alternatively, if the
mrt1 and mrt3 mutations are required only for modulating the
rate of deadenylation-dependent decapping, then they would
not be expected to affect the decay of a transcript with an early
nonsense codon.
To perform this experiment, we transformed the mrt1 and
mrt3 strains with a plasmid expressing a PGK1pG transcript
containing an early nonsense codon, termed B55TPGK1N103pG
(24). Since this mRNA is under the transcriptional control of
the GAL1 UAS, we measured its decay rate following inhibi-
tion of transcription by the addition of glucose. As shown in
Fig. 6, the mrt1-3 and mrt3-1 mutations do not significantly
affect the decay rate of the B55TPGK1N103pG transcript. In
agreement with these results, the mrt1-3 and mrt3-1 mutations
do not affect the rapid decay of the inefficiently spliced pre-
cursor to the CYH2 mRNA (Table 2), which is thought to be
degraded by the same mechanism that degrades transcripts
containing early nonsense codons (13). These results demon-
strated that the MRT1 and MRT3 gene products are not in-
volved in deadenylation-independent decapping and suggested
that they may specifically function to modulate rates of decap-
ping following deadenylation (see discussion).
mrt1 and mrt3 mutants contain normal levels of the mRNA
decapping activity. The previous results suggested that the
mrt1-3 and mrt3-1 mutants must contain at least some decap-
ping activity. To directly test the levels of decapping activity in
these mutants, we assayed cell extracts from wild-type, mrt1,
andmrt3 strains for the decapping activity recently shown to be
required for mRNA decay (2). This experiment demonstrated
that cell extracts from both mrt mutants contain essentially
wild-type levels of in vitro decapping activity (relative decap-
ping activities were 1.0 for wild type, 0.9 for mrt1-3, and 1.2 for
mrt3-1). This observation implies that mrt1 and mrt3 lesions
may affect the rates of mRNA decapping by altering the inter-
action of the decapping enzyme with its substrate (see Discus-
sion).
Mutations in the MRT1, MRT3, and DCP1 genes suppress
the lethality of pab1D. The above results suggested that the
MRT1 and MRT3 gene products promote mRNA decapping.
However, decapping can also be negatively controlled. For
example, since decapping generally occurs following deadeny-
lation, the poly(A) tail can be considered an inhibitor of
mRNA decapping. This negative affect on decapping requires
the poly(A) binding protein (Pab1p) (31), since mRNAs are
decapped prior to deadenylation in pab1D strains (5). It was
hypothesized that such deadenylation-independent decapping
in pab1D strains might result in the premature degradation of
mRNAs, thereby contributing to the lethality of pab1D. This
model was supported by the observation that inhibition of
mRNA turnover downstream of decapping, by deletion of the
XRN1 gene, suppresses the lethality of pab1D (5). A prediction
of this model is that mutations that inhibit mRNA decapping
should suppress the lethality of pab1D. To test this possibility,
we examined whether the mrt1, mrt3, and/or dcp1-1 lesion
could suppress the lethality of pab1D by a standard genetic
cross (see Materials and Methods). As shown in Fig. 7, muta-
tions in the MRT1, MRT3, and DCP1 genes suppress the le-
thality of pab1D. These observations suggest that one class of
suppressors of pab1D lethality will be those that alter mRNA
degradation following deadenylation (see reference 5).
DISCUSSION
Two pathways of mRNA turnover converge on mRNA de-
capping. Two different but related pathways of mRNA degra-
dation utilize mRNA decapping to expose transcripts to 59-
to-39 exonucleolytic degradation (for a review, see reference
1). One of these pathways is a mechanism whereby mRNAs are
deadenylated and then decapped. This process of mRNA de-
cay appears to function on normal yeast mRNAs spanning a
wide range of decay rates (8, 21, 22). A related pathway of
degradation functions on mRNAs that contain early nonsense
codons wherein transcripts are decapped without prior dead-
enylation (11, 24). Several lines of evidence suggest that these
two pathways converge at a common step of mRNA decapping
(Fig. 8). First, both pathways require the function of the same
decapping enzyme, which is encoded by the DCP1 gene (2).
Similarly, following decapping, the same 59-to-39 exonuclease,
Xrn1p, degrades the body of the transcript (11, 16, 21, 22, 24).
FIG. 6. mrt mutations do not inhibit the decay of PGK1pG mRNA contain-
ing an early nonsense codon; measurement of decay of a PGK1pG transcript
containing an early nonsense codon (B55TPGK1N103pG) (24). In this experiment,
a plasmid expressing the B55TPGK1N103pG transcript under the control of the
GAL1UAS (pRP611 [24]) was introduced into a wild-type strain (WT) (yRP840)
and mrt1-3 (yRP1066) and mrt3-1 (yRP1067) mutants. Transcription was re-
pressed at zero time by the addition of glucose, and the levels of B55TPGK1N103pG
present were determined by probing with an oligonucleotide probe specific for
the B55TPGK1N103pG mRNA, oRP252 (59-CTTGGACAGAGATCAATTCG-
39). This probe is complementary to an oligonucleotide inserted at position 55 of
the PGK1 sequence in the B55TPGK1N103pG transcript and PGK1 mRNA se-
quence 39 of the tag. t1/2, half-life.
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Finally, the convergence of these pathways is supported by the
observation that the 59 end of the decapped transcript is the
same in deadenylation-independent and deadenylation-depen-
dent decapping (cf. references 22 and 24). In both of these
pathways, different features of transcripts including the
poly(A) tail, the status of translation termination, and specific
mRNA sequences need to be recognized and utilized to affect
the rate of the decapping reaction.
Identification of mutations affecting mRNA decapping. In
this work, we have identified mutations in two genes, MRT1
and MRT3, that affect mRNA decay. Since these recessive
mutations lead to the stabilization of mRNAs, the MRT1 and
MRT3 gene products presumably function to promote mRNA
degradation. Several lines of evidence indicated that mutations
in these genes primarily lead to an inhibition of mRNA de-
capping. First, in transcriptional pulse-chase analysis of the
mrt1 and mrt3 mutants, MFA2pG transcripts are deadenylated
essentially normally but persist as full-length deadenylated spe-
cies (Fig. 3). Second, immunoprecipitation of MFA2pG tran-
scripts showed that the full-length deadenylated transcripts
that accumulate in the mrt mutants have a cap structure (Fig.
4). Third, primer extension analysis of the PGK1pG transcript
detects only a full-length species and not a species lacking 2
bases at the 59 end that is detected in strains blocked at 59-to-39
exonucleolytic degradation (Fig. 5). We interpret these obser-
vations to indicate that the MRT1 and MRT3 gene products
promote mRNA decapping. We have shown by complementa-
tion and linkage analysis that the MRT1 and MRT3 genes are
distinct from the DCP1 gene, which encodes the decapping
enzyme or a necessary component of the decapping complex
required for mRNA decapping in vivo (2). Thus, at the present
time, the products of the MRT1 and MRT3 genes and Dcp1p
represent the three gene products known to affect mRNA
decapping.
Two classes of gene products affect mRNA decapping. The
three gene products defined by the MRT1, MRT3, and DCP1
loci fall into two classes with regard to their role in mRNA
decapping. The first class consists of gene products required
for the production of active decapping enzyme and thereby
should affect both deadenylation-dependent and deadenyla-
tion-independent decapping. The only known member of this
class is the DCP1 gene (2). Strains from which the DCP1 gene
is deleted are defective in deadenylation-dependent and dead-
enylation-independent decapping and show no decapping ac-
tivity when assayed in cell extracts. A point mutation in this
gene, dcp1-1, which was isolated during this work, shows phe-
notypes similar to that of dcp1D (2). One might predict that
FIG. 7. Mutations that inhibit mRNA decay suppress pab1D. YEPD plate on which pab1D strains in combination with the mutations shown were streaked for single
colonies at 248C. Strains shown include yRP881 (spb2D pab1D), yRP903 (xrn1D pab1D), yRP1110 (mrt1-3 pab1D), yRP1111 (mrt1-2 pab1D), yRP1112 (dcp1-1 pab1D),
and yRP1113 (mrt3-1 pab1D). The wild-type (WT) strain used for comparison was yRP840. The spb2D mutation, which suppresses pab1D lethality (32), was used as
a positive control for pab1D growth suppression.
FIG. 8. Model of MRT gene product function; converging pathways of dead-
enylation-dependent decay of normal mRNAs and the deadenylation-indepen-
dent decapping of transcripts containing premature stop codons. The positions at
which various gene products are thought to function, including the MRT gene
products, are shown.
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other gene products that fall into this class of decapping gene
products will be isolated. These gene products could function
to increase the level of expression of Dcp1p or to modulate its
enzymatic activity, perhaps as another subunit of a decapping
complex or by posttranslational modification of Dcp1p.
The second class of gene products affecting mRNA decap-
ping consists of the products of theMRT1 andMRT3 genes. In
contrast to the general effects of dcp1D, mutations in these
genes do not affect deadenylation-independent decapping (Fig.
6; also see Table 2 [CYH2 precursor mRNA]) and therefore
may be functionally limited to transcripts that require dead-
enylation before decapping (depicted in Fig. 8). This model is
supported by the demonstration that cell extracts from mrt1-3
and mrt3-1 strains show normal levels of decapping activity. In
this light, it is striking to note that some mRNAs are affected
differently by the mrt1-3 and mrt3-1 lesions. For example, the
GAL10 transcript is stabilized by a mrt1-3 lesion but is not
affected by an mrt3-1 mutation. This raises the possibility that
the MRT1 and MRT3 gene products are involved in determin-
ing mRNA-specific rates of decapping following deadenyla-
tion.
An important issue is how mrt1 and mrt3 mutations inhibit
mRNA decapping. Previous observations have shown that in-
hibition of translational elongation, because of either cyclohex-
imide (e.g., see reference 14) or the cca1-1 mutation (28), can
stabilize mRNAs. This raises the possibility that the mrt1 and
mrt3 lesions inhibit mRNA decapping as a secondary conse-
quence of an inhibition of translation in these mutants. Al-
though we cannot formally rule out this possibility, the mRNA-
specific effects observed in the mrt1 and mrt3 mutants are
different from the general stabilization of all mRNAs exam-
ined because of the inhibition of translation resulting from
cycloheximide or cca1-1.
Two general models may explain how the MRT1 and MRT3
gene products more directly affect decapping rates. In one
view, these gene products are envisioned to interact with
Dcp1p in a manner that would recruit Dcp1p to the mRNA
after deadenylation and thus promote decapping. An appeal-
ing alternative view is suggested by the proposed role of the
UPF gene products in the decay of mRNAs with early non-
sense codons. In that case, the UPF gene products have been
hypothesized to function in sensing premature termination and
subsequently alter the mRNP structure at the 59 end of the
transcript to allow rapid deadenylation-independent decapping
(6, 11, 17, 24, 29). By analogy to this model, the MRT1 and
MRT3 gene products may promote the formation of or stabi-
lize a particular mRNP structure, after loss of the poly(A) tail,
that is susceptible to decapping by Dcp1p. In this model, mod-
ulation of decapping rate by specific mRNA features could
affect the interaction of proteins such as translation initiation
factors with the 59 cap structure, thereby sterically competing
with the decapping activity. Such a model is appealing in that
it provides a mechanistic basis for the interrelationship be-
tween the translation and turnover of eukaryotic mRNAs.
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